Easton Pharmaceutica Net Income
Easton Pharmaceutica technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.
Easton Pharmaceutica Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 5.6431 | Revenue | Revenue Per Share |
| Last Reported | Projected for Next Year | ||
| Net Loss | -216.8 K | -227.7 K | |
| Net Loss | -216.8 K | -227.7 K | |
| Net Loss | -216.8 K | -227.7 K |
Easton | Net Income | Build AI portfolio with Easton Stock |
The Net Income trend for Easton Pharmaceutica offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Easton Pharmaceutica is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Easton Pharmaceutica's Net Income Growth Pattern
Below is the plot of the Net Income of Easton Pharmaceutica over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Easton Pharmaceutica financial statement analysis. It represents the amount of money remaining after all of Easton Pharmaceutica operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Easton Pharmaceutica's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Easton Pharmaceutica's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (188.54 K) | 10 Years Trend |
|
Net Income |
| Timeline |
Easton Net Income Regression Statistics
| Arithmetic Mean | (285,580) | |
| Coefficient Of Variation | (65.29) | |
| Mean Deviation | 126,519 | |
| Median | (188,542) | |
| Standard Deviation | 186,445 | |
| Sample Variance | 34.8B | |
| Range | 703.6K | |
| R-Value | 0.22 | |
| Mean Square Error | 35.2B | |
| R-Squared | 0.05 | |
| Significance | 0.39 | |
| Slope | 8,291 | |
| Total Sum of Squares | 556.2B |
Easton Net Income History
Other Fundumenentals of Easton Pharmaceutica
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Easton Pharmaceutica Net Income component correlations
Easton Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Easton Pharmaceutica is extremely important. It helps to project a fair market value of Easton Stock properly, considering its historical fundamentals such as Net Income. Since Easton Pharmaceutica's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Easton Pharmaceutica's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Easton Pharmaceutica's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Pharmaceuticals market expansion? Will Easton introduce new products? Factors like these will boost the valuation of Easton Pharmaceutica. Projected growth potential of Easton fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Easton Pharmaceutica's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Easton Pharmaceutica should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Easton Pharmaceutica's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Easton Pharmaceutica 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Easton Pharmaceutica's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Easton Pharmaceutica.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in Easton Pharmaceutica on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Easton Pharmaceutica or generate 0.0% return on investment in Easton Pharmaceutica over 90 days. Parallel Industries Inc. does not have significant operations More
Easton Pharmaceutica Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Easton Pharmaceutica's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Easton Pharmaceutica upside and downside potential and time the market with a certain degree of confidence.
Easton Pharmaceutica Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Easton Pharmaceutica's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Easton Pharmaceutica's standard deviation. In reality, there are many statistical measures that can use Easton Pharmaceutica historical prices to predict the future Easton Pharmaceutica's volatility.Easton Pharmaceutica Backtested Returns
We have found zero technical indicators for Easton Pharmaceutica, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Easton Pharmaceutica are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Easton Pharmaceutica has no correlation between past and present. Overlapping area represents the amount of predictability between Easton Pharmaceutica time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Easton Pharmaceutica price movement. The serial correlation of 0.0 indicates that just 0.0% of current Easton Pharmaceutica price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Easton Operating Income
Operating Income |
|
Based on the recorded statements, Easton Pharmaceutica reported net income of (188,542). This is 100.06% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 100.03% higher than that of the company.
Easton Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Easton Pharmaceutica's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Easton Pharmaceutica could also be used in its relative valuation, which is a method of valuing Easton Pharmaceutica by comparing valuation metrics of similar companies.Easton Pharmaceutica is currently under evaluation in net income category among its peers.
Easton Fundamentals
| Return On Equity | -0.0269 | ||||
| Return On Asset | -0.0083 | ||||
| Current Valuation | 2.14 M | ||||
| Shares Outstanding | 1.34 B | ||||
| Price To Earning | (22.00) X | ||||
| Price To Book | 0 X | ||||
| Price To Sales | 0.06 X | ||||
| Gross Profit | 201.4 K | ||||
| EBITDA | (188.54 K) | ||||
| Net Income | (188.54 K) | ||||
| Cash And Equivalents | 5.81 K | ||||
| Total Debt | 3.28 M | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 0.69 X | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (188.54 K) | ||||
| Beta | 27.54 | ||||
| Market Capitalization | 13.45 K | ||||
| Total Asset | 10.19 M | ||||
| Retained Earnings | (39.82 M) | ||||
| Working Capital | (194.5 K) | ||||
| Current Asset | 297 K | ||||
| Current Liabilities | 137 K | ||||
| Net Asset | 10.19 M |
About Easton Pharmaceutica Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Easton Pharmaceutica's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Easton Pharmaceutica using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Easton Pharmaceutica based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is there potential for Pharmaceuticals market expansion? Will Easton introduce new products? Factors like these will boost the valuation of Easton Pharmaceutica. Projected growth potential of Easton fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Easton Pharmaceutica's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Easton Pharmaceutica should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Easton Pharmaceutica's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.